Abiopharma

🔍 Chiprin Jeff (Executive)

Company: IRADIMED CORP (IRMD)

Report Date: 2025-12-11

Detailed Transactions and Holdings:

• Acquired 996 shares of Common Stock (Direct)
  Date: 2025-12-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 996.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 309 shares of Common Stock at $97.38 per share (Direct)
  Date: 2025-12-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 687.00 | transaction_form_type: 4
• Sold 996 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,994.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.